$157.34
-1.28-0.81%
al cierre: Aug 18, 5:00 PM EST
$157.34
N/A
After hour: 4:20 PM EST
Protagonist Therapeutics Inc
PTGXNASDAQ
Protagonist Therapeutics Earnings & Forecasts
Protagonist Therapeutics (PTGX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Protagonist Therapeutics Guidance
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $1.84 | $-0.65 | $-0.54 | $-0.62 |
| Actual | $2.29 | $0.05 | $-0.69 | $-0.62 |
| Surprise | +24.5% | +107.7% | -27.8% | 0.00% |
| Revenue | ||||
| Estimate | $213.1M | $14.0M | $14.3M | $6.5M |
| Actual | $213.5M | $56.4M | $7.4M | $4.7M |
| Surprise | +0.16% | +302.1% | -47.9% | -27.3% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $2.43 | $-0.45 | $-0.62 | $-0.17 |
| Revenue | ||||
| Consensus | $244.1M | $31.4M | — | — |